Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.
- DOI
- 10.1182/bloodadvances.2025018760
- Published
- 2026 Mar 10
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025018760,
title = {Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.},
author = {Bär I and Groten SA and Barraclough A and Bürgisser PE and van Kwawegen C and Lenting PJ and van Moort I and Eikenboom JCJ and Leebeek FWG and Voorberg J and van den Biggelaar M and Bierings R},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2025018760},
url = {https://doi.org/10.1182/bloodadvances.2025018760}
}RIS
TY - JOUR TI - Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9. AU - Bär I AU - Groten SA AU - Barraclough A AU - Bürgisser PE AU - van Kwawegen C AU - Lenting PJ AU - van Moort I AU - Eikenboom JCJ AU - Leebeek FWG AU - Voorberg J AU - van den Biggelaar M AU - Bierings R PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2025018760 UR - https://doi.org/10.1182/bloodadvances.2025018760 ER -
APA
I, B., SA, G., A, B., PE, B., C, V. K., PJ, L., I, V. M., JCJ, E., FWG, L., J, V., M, V. D. B., & R, B. (2026). Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.. Blood advances. https://doi.org/10.1182/bloodadvances.2025018760
Source records
- pubmed · retrieved 2026-09-26T21:53:21.846Z